Target intelligence / Profile preview

Bacterial RNA polymerase (RNAP)

Target
RNAP
Molecular classification
Enzyme, Transferase, Protein complex
01

Overview

Bacterial RNA polymerase (RNAP) is the central enzyme of the bacterial transcription machinery, responsible for synthesizing all cellular RNA from a DNA template. The core enzyme is a multi-subunit complex composed of five subunits (two alpha, one beta, one beta-prime, and one omega), which associates with a dissociable sigma factor to form the transcriptionally competent holoenzyme. This machinery is highly conserved across bacterial species but structurally distinct from eukaryotic RNA polymerases, making it an excellent target for selective broad-spectrum and narrow-spectrum antibacterial therapies. Clinically approved drugs targeting this machinery include the rifamycins (such as rifampicin, rifabutin, and rifaximin), which bind to the beta-subunit and sterically block RNA elongation, and fidaxomicin, which inhibits transcription initiation. A major therapeutic challenge associated with targeting bacterial RNAP is the rapid emergence of drug resistance, primarily driven by single-nucleotide polymorphisms in the rpoB gene, as well as significant drug-drug interactions caused by the induction of hepatic cytochrome P450 enzymes by certain rifamycins.

Other names
Bacterial RNA-polymerase-associated transcription machineryBacterial RNA polymeraseBacterial RNAPDNA-directed RNA polymeraseBacterial transcription machineryRNA polymerase holoenzyme
02

Mechanism of action

Inhibition of bacterial transcription by binding to the RNA polymerase beta subunit to block RNA elongation, preventing transcription initiation by binding the DNA-RNAP complex, or inhibiting transcription termination factors like Rho.

03

Biological functions

TranscriptionRNA synthesisGene expression
04

Disease associations

Infection
05

Safety considerations

Cytochrome P450 induction leading to severe drug-drug interactionsHepatotoxicityGastrointestinal distressRapid development of drug resistance via single-nucleotide polymorphisms
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

rpoB gene mutationsSputum culture conversionClostridioides difficile toxin clearanceMinimum inhibitory concentration

Beyond the preview

Go deeper on Bacterial RNA polymerase (RNAP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial RNA polymerase (RNAP).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call